Client information

Amount

Johnson & Johnson

$44,706.04

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2014 Area of focus for 2014 will be any issues that impact Johnson & Johnson companies. These areas will likely linclude but not be limited to medical device, consumer, pharmaceutical, health care reform, wellness initiatives, tax, and environment. Specific legislation known at this time: HB 235 - An Act for healthy families and businesses HB 541 - An Act to establish an Alzheimer's state plan commission HB 678 - An Act authorizing a special commission to study cytotoxic drugs in the environment HB 729 - An Act establishing the commission on extended producer responsibility HB 741 -An Act to create a framework to re-allocate responsibility for discarded products HB 803 -An Act to require producer responsibility for collection, reuse and recycling of discarded electronic products HB 825 -An Act regulating the disposal of prescription medication. HB 948 -An Act to expand coverage and access to behavioral health services HB 1008 - An Act relative to patient safety HB 1715 - An Act relative to non-competition agreements HB 1933 -An Act establishing provisions for the return of expired pharmaceuticals HB 1940 -An Act relative to safe disposal of medical sharps HB 1942 - An Act relative to office-based surgery HB 1955 An Act to establish a model program for pharmacists as public health partners HB 1968- An Act regarding sharps and medications HB 1977 - An Act relative to drug disposal by mail HB 1990 - An Act relative to safe cosmetics in the Commonwealth of Massachusetts HB 2018 - An Act to define modest meals and refreshments in prescriber educational settings HB 2020 - An Act to reduce healthcare costs by promoting non-biased prescriber education HB 2021 - An Act providing for a viral hepatitis prevention, screening, treatment and education program HB 2033 – An Act relative to safe disposal of prescription drugs. HB 2060- An Act recognizing pharmacists as healthcare providers. HB 2078 - An Act relative to the Massachusetts Alzheimer’s project HB 2082 –An Act establishing a statewide discount program for pharmaceuticals HB 2126 - An Act reducing prescription drug abuse HB 2646 - An Act to eliminate the tax deduction for direct to consumer pharmaceutical marketing HB 2085 -An Act relative to the establishment of a commission to modernize HIV/AIDS Prevention and treatment HB 3711 - An Act relative to emergency scheduling of addictive substances by the Commissioner of Public Health. HB 3734 – An Act relative to biosimilars SB 346 -An Act to create a framework to re-allocate responsibility for discarded products SB 387 - An Act for a competitive economy through safer alternatives to toxic chemicals SB 399- An Act relative to regulation of discharge of pharmaceutical and personal care product-laden wastewater into private drinking water wells and municipal drinking water supplies SB 484 -An Act recognizing pharmacists as health care providers SB 543 - An Act to ensure the privacy of patient prescription records SB 557 - An Act relative to patient safety SB 846 -An Act relative to employee non-competition agreements SB 1032 -An Act relative to the in-office sales of medical devices and products SB 1050 - An Act to reduce health care costs by promoting evidence-based prescriber education SB 1052 - An Act to restore integrity in the marketing of pharmaceutical products and medical devices SB 1089 -An Act relative to home generated sharps management SB 1094 -An Act establishing a statewide discount program for pharmaceuticals Implementation of Chapter 224 (2012) SB 2231 An Act Promoting Econmic Growth Across the Commonwealth HB 4164 An Act Promoting Econmic Growth Across the Commonwealth SB 2133/2142 An Act to increase opportunities for long-term substance abuse recovery HB 4236 An Act to increase opportunities for long-term substance abuse recovery HB 4001 Section 71 Copay Assistance

Total salaries received:      $44,706.04

Expenditures

Amount